Tian Zhaoxia, Sheng Ruishan, Zhang Yutong, Li Hongmei
Department of Nursing, Fenyang College of Shanxi Medical University, Fenyang City, Shanxi Province, People's Republic of China.
Cancer Manag Res. 2025 Jul 1;17:1259-1269. doi: 10.2147/CMAR.S509857. eCollection 2025.
Emotional expression conflicts, characterized by approach-avoidance dilemmas in self-disclosure, are prevalent among breast cancer patients undergoing postoperative chemotherapy. This study identifies emotional expression conflict subtypes and their predictors to inform targeted interventions.
This cross-sectional study employed convenience sampling to recruit 238 postoperative breast cancer patients. The assessment protocol comprised three validated instruments: the Ambivalence over Emotional Expressiveness Questionnaire-G28 for emotional conflict evaluation, the Cognitive Fusion Questionnaire for cognitive assessment, and the Family Resilience Assessment Scale for family dynamics measurement. Latent profile analysis was conducted to characterize distinct emotional expression conflict subtypes, with subsequent multivariate logistic regression modeling to identify significant predictors.
Three distinct emotional expression conflict profiles emerged: (a) Low conflict-emotion expression (33.6%): Proactive emotional sharing with minimal ambivalence. (b) Medium conflict-emotion expression (42.4%): Context-dependent disclosure with moderate ambivalence. (c) High conflict-expression blocked (23.9%): Suppression-dominated behavior with severe ambivalence. Younger age, lower education, reduced income, poor sleep quality, and higher cognitive fusion significantly increased the likelihood of high emotional conflict. Conversely, stronger family resilience was associated with reduced conflict risk.
This study highlights the clinical significance of heterogeneity in emotional expression conflicts among breast cancer patients. By targeting modifiable factors (such as sleep quality, cognitive fusion), oncology nursing may advance personalized psychosocial support to address these conflicts. Such strategies demonstrate global applicability for effectively alleviating patient distress and enhancing patient-centered care outcomes.
情感表达冲突以自我表露中的趋近-回避困境为特征,在接受术后化疗的乳腺癌患者中普遍存在。本研究旨在确定情感表达冲突的亚型及其预测因素,为针对性干预提供依据。
本横断面研究采用便利抽样法招募了238例乳腺癌术后患者。评估方案包括三种经过验证的工具:用于情感冲突评估的《情感表达矛盾问卷-G28》、用于认知评估的《认知融合问卷》以及用于家庭动态测量的《家庭复原力评估量表》。进行潜在剖面分析以刻画不同的情感表达冲突亚型,随后进行多变量逻辑回归建模以确定显著的预测因素。
出现了三种不同的情感表达冲突类型:(a)低冲突-情感表达型(33.6%):积极的情感分享,矛盾心理最小。(b)中等冲突-情感表达型(42.4%):依情境而定的表露,矛盾心理适中。(c)高冲突-表达受阻型(23.9%):以抑制为主导的行为,矛盾心理严重。年龄较小、教育程度较低、收入减少、睡眠质量差以及认知融合程度较高显著增加了高情感冲突的可能性。相反,更强的家庭复原力与冲突风险降低相关。
本研究强调了乳腺癌患者情感表达冲突异质性的临床意义。通过针对可改变的因素(如睡眠质量、认知融合),肿瘤护理可以推进个性化的心理社会支持以解决这些冲突。此类策略显示出在有效减轻患者痛苦和提高以患者为中心的护理结果方面的全球适用性。